Exploring Innovations in Flow Cytometry as a MRD and CDx Modality
Time: 3:10 pm
day: Day Two Track C
Details:
- Join our talk and panel discussion to delve into the latest updates and developments in the use of flow cytometry as a MRD and companion diagnostic (CDx) modality.
- This session will provide insights into the decision-making process, highlighting when flow cytometry is the optimal choice for biopharma companies in their drug development journey.
- Discover how this powerful tool can enhance precision medicine and accelerate the path to successful therapies.
